AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Report Publication Announcement Sep 19, 2019

3714_rns_2019-09-19_7eb5714a-0fdb-4912-9c6b-5cc31cb4f697.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Photocure to present at Norne Securities Vekst & Verdi Aksjeseminar in Vilnius

Photocure to present at Norne Securities Vekst & Verdi Aksjeseminar in Vilnius

Oslo, Norway, 19 September 2019, Photocure ASA (OSE: PHO) management will be

presenting at the Norne Securities Vekst & Verdi Aksjeseminar in Vilnius,

Lithuania on September 20 at 14:25 EEST/13:25 CEST.

The conference is sponsored by Norne Securities. The presentation will be posted

on www.photocure.com when held on September 20, 2019.

Company contact:

Erik Dahl

Chief Financial Officer

Tel: +47 450 55 000

Email: [email protected]

About Photocure ASA

Photocure, The Bladder Cancer Company, delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, which makes

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.